logo-loader

Evgen Pharma plc

Receive alerts
Market:
AIM
Market Cap:
£18.74 m
Price
14.13 GBX
Change
-2.59%
52 weeks high
33.00
52 weeks low
13.25

In brief

Evgen Pharma PLC, a clinical stage drug development company focused on the treatment of cancer and neurological conditions.